Loading...

Purified anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
Compare all formats
Cat # Size Price Quantity Check Availability Save
123101 50 µg £33
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123102 500 µg £177
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Elshal M, et al. 2022. Arch Pharm Res. . PubMed
  2. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  3. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  4. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  5. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  6. Rehrauer H, et al. 2018. Oncogene. 7:1487250. PubMed
  7. Gomes AC, et al. 2019. J Immunol. 203:2485. PubMed
  8. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  9. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  10. Cheng AA, et al. 2021. Am J Physiol Endocrinol Metab. 320:E438. PubMed
  11. Nobs SP, et al. 2021. J Allergy Clin Immunol. . PubMed
  12. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  13. Maestro S, et al. 2021. Viruses. 13: . PubMed
  14. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  15. Kaneko T, et al. 2012. J Immunol. 188:5397. PubMed
  16. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  17. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  18. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  19. Gray ME, et al. 2018. J Biomed Mater Res B Appl Biomater. 107(5):1620-1633. PubMed
  20. Wang B et al. 2018. Cell stem cell. 22(2):206-220 . PubMed
  21. Zou B, et al. 2017. PLoS Pathogens. 13(6):e1006436. PubMed
  22. Accarias S, et al. 2020. J Cell Sci. 133:. PubMed
  23. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  24. Lu L, et al. 2022. Sci Rep. 12:931. PubMed
  25. Yang J, et al. 2022. Biosci Rep. :. PubMed
  26. Elshal M, et al. 2022. Inflammopharmacology. :. PubMed
  27. Chen YS, et al. 2019. Cells. 8:3. PubMed
  28. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  29. Karnezis T et al. 2019. Cancer Res. 79(7):1558-1572 . PubMed
  30. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  31. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  32. Duvvuri M, et al. 2019. Biomater Sci. 7:1863. PubMed
  33. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  34. De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
  35. Xu Q, et al. 2021. Front Physiol. 12:732084. PubMed
  36. Kennedy CL, et al. 2021. Toxics. 9:. PubMed
  37. Goswami S, et al. 2021. J Cell Physiol. 236:8148. PubMed
  38. Cai Z, et al. 2021. Front Immunol. 12:646384. PubMed
  39. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  40. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  41. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  42. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  43. Chen J, et al. 2018. Hypertension. 71:877. PubMed
  44. Weis S et al. 2017. Cell. 169(7):1263-1275 . PubMed
  45. Cvetanova B, et al. 2021. Int J Mol Sci. 22: . PubMed
  46. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  47. Huang YL, et al. 2021. Antioxidants (Basel). 10:. PubMed
  48. Peng J, et al. 2020. Toxicol Res (Camb). 9:609. PubMed
  49. Huang YL, et al. 2021. Aging Cell. 20:e13523. PubMed
  50. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  51. Wada N, et al. 2020. Mol Metab. 37:100988. PubMed
  52. Malsy J, et al. 2020. Elife. 9:00. PubMed
  53. Cozzitorto C, et al. 2020. Developmental Cell. 55(2):150-162.e6. PubMed
  54. Wang Y, et al. 2021. Cancer Cell. 39:1375. PubMed
  55. Ma F, et al. 2020. Sci Signal. :13. PubMed
  56. Motoyama S, et al. 2020. Cells. :9. PubMed
  57. Cheng Y, et al. 2018. J Exp Med. 215:2919. PubMed
  58. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  59. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  60. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  61. Yang M, et al. 2020. Oncoimmunology. 9:1708064. PubMed
  62. Miyake M, et al. 2021. iScience. 24:103448. PubMed
  63. Billerhart M, et al. 2021. Mol Ther Oncolytics. 23:192. PubMed
  64. Kuziel G, et al. 2020. Cancers (Basel). 12:00. PubMed
  65. Hayakawa K, et al. 2016. J Cereb Blood Flow Metab. 36: 781-793. PubMed
  66. Do DC, et al. 2019. JCI Insight. 4:e126832. PubMed
  67. Kitai Y, et al. 2017. J Immunol. 198:1649. PubMed
  68. Nakamizo S,et al. 2017. Sci Rep. . 10.1038/s41598-017-14292-1. PubMed
  69. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  70. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  71. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  72. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  73. Bálint L, et al. 2020. Front Immunol. 2.529861111. PubMed
  74. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  75. Matsuo R, et al. 2022. JID Innov. 2:100141. PubMed
  76. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  77. Shaker ME, et al. 2022. Saudi Pharm J. 30:291. PubMed
  78. Oba T, et al. 2021. J Immunother Cancer. 9:. PubMed
  79. Li Y, et al. 2021. Cardiovasc Res. 890:117. PubMed
  80. Cassidy LD, et al. 2018. Autophagy. 1.455555556. PubMed
  81. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  82. Tsujinaka H, et al. 2020. Nat Commun. 0.940277778. PubMed
  83. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  84. Rätsep MT, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L977. PubMed
  85. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  86. Wang Y, et al. 2021. Sci Transl Med. 13:. PubMed
  87. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  88. Yang K, et al. 2017. Nature. 548:602. PubMed
  89. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  90. Kobayashi M, et al. 2008. J Leukoc Biol. 83:1354. PubMed
  91. Andersson &, et al. 2011. Clin Cancer Res. 3.25. PubMed
  92. Kaufmann B, et al. 2022. EMBO Rep. 23:e54446. PubMed
  93. Hu G, et al. 2021. Nat Commun. 12:773. PubMed
  94. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  95. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  96. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  97. Mueller–Ortiz SL, et al. 2019. J Immunol. 203:2701. PubMed
  98. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  99. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  100. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  101. Tsai F, et al. 2017. J Exp Med. 214:3753. PubMed
  102. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  103. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  104. Janardhan KS, et al. 2018. Toxicol Pathol. 46:488. PubMed
  105. Defaye M, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:977. PubMed
  106. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  107. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  108. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  109. Piao Y, et al. 2016. Neuro Oncology. 18: 1230 - 1241. PubMed
  110. Poeckel D, et al. 2009. J Biol Chem. 284:21077. PubMed
  111. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  112. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  113. Wu Y, et al. 2020. Biol Reprod. 1213:102. PubMed
  114. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  115. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  116. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  117. Jokinen MP, et al. 2017. Toxicol Pathol. 45:774. PubMed
  118. Ford J, et al. 2019. Front Immunol. 2.502083333. PubMed
  119. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  120. Hosomi K, et al. 2022. Nat Commun. 13:4477. PubMed
  121. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  122. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  123. Sasi S, et al. 2014. J Biol Chem. 289:14178. PubMed
  124. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  125. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  126. Burns K, et al. 2012. Endocrinology. 153:3960. PubMed
  127. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  128. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  129. Lever JM, et al. 2019. JCI Insight. 4:e125503. PubMed
  130. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  131. Hong JE, et al. 2019. Front Microbiol. 0.727083333. PubMed
  132. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  133. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  134. Liu J, et al. 2022. Small. 18:e2106172. PubMed
  135. Li X, et al. 2021. Eur J Immunol. 51:2452. PubMed
  136. Yang CC, et al. 2021. Cancers (Basel). 13:. PubMed
  137. Um HN, et al. 2021. Cell Death Dis. 12:243. PubMed
  138. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  139. McArthur S, et al. 2020. J Clin Invest. 130:1156. PubMed
  140. Dyrna F, et al. 2018. Am J Sports Med. 46:3511. PubMed
  141. Burger ML, et al. 2021. Cell. 184:4996. PubMed
  142. Yi X, et al. 2021. J Bone Miner Res. 36:2426. PubMed
  143. Thakur V, et al. 2014. Toxicol Lett. 230:322. PubMed
  144. Quilichini E, et al. 2019. Cell Mol Gastroenterol Hepatol. 0.671527778. PubMed
  145. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  146. Hunt LC, et al. 2021. Cell Rep. 37:109971. PubMed
  147. Nagatake T, et al. 2021. Sci Rep. 11:10426. PubMed
  148. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  149. Kikuchi N, et al. 2011. Am J Respir Cell Mol Biol. 45:600. PubMed
  150. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  151. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  152. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  153. Baluk P, et al. 2022. Methods Mol Biol. 2441:115. PubMed
  154. Rios–Doria J, et al. 2017. Cancer Res. 77:2686. PubMed
  155. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  156. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  157. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  158. Campbell KM, et al. 2019. Cell Rep. 28:1526. PubMed
  159. Ireland L, et al. 2018. Oncogene. 293:4244. PubMed
RRID
AB_893504 (BioLegend Cat. No. 123101)
AB_893506 (BioLegend Cat. No. 123102)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org
Go To Top Version: 2    Revision Date: 10/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account